NPI: 1083669089 · CANTON, MS 39046 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 05/24/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 05/24/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,514 | $467K |
| 2019 | 15,783 | $462K |
| 2020 | 15,816 | $459K |
| 2021 | 15,043 | $402K |
| 2022 | 8,130 | $301K |
| 2023 | 7,330 | $365K |
| 2024 | 2,600 | $212K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,004 | 2,589 | $2.30M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,385 | 1,276 | $214K |
| A4657 | Syringe, with or without needle, each | 7,118 | 1,689 | $82K |
| 83970 | 1,026 | 833 | $25K | |
| J1756 | Injection, iron sucrose, 1 mg | 3,644 | 864 | $14K |
| J1270 | Injection, doxercalciferol, 1 mcg | 14,209 | 1,203 | $8K |
| 82728 | 616 | 577 | $7K | |
| 83550 | 540 | 522 | $4K | |
| 83540 | 628 | 585 | $3K | |
| 90674 | 76 | 70 | $2K | |
| 85045 | 588 | 560 | $2K | |
| 85041 | 886 | 825 | $2K | |
| 85048 | 885 | 822 | $1K | |
| 82108 | 40 | 38 | $569.02 | |
| 82746 | 31 | 27 | $419.99 | |
| 82607 | 28 | 25 | $398.71 | |
| 0012A | 36 | 15 | $282.84 | |
| G0008 | Administration of influenza virus vaccine | 69 | 61 | $98.14 |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 334 | 150 | $0.00 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,073 | 698 | $0.00 |